Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Recruiting
Observational Study
Cardiac Amyloidosis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 80 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 637 (estimated)
- Sponsor
- Gérond'if · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged ≥ 80 years
* Hospitalised for decompensation of heart failure in the last 12 months
* Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm)
* Subjects able to undergo a bone scintigraphy scan
* Subjects willing to participate…
Contacts